JP2019520365A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520365A5
JP2019520365A5 JP2018568285A JP2018568285A JP2019520365A5 JP 2019520365 A5 JP2019520365 A5 JP 2019520365A5 JP 2018568285 A JP2018568285 A JP 2018568285A JP 2018568285 A JP2018568285 A JP 2018568285A JP 2019520365 A5 JP2019520365 A5 JP 2019520365A5
Authority
JP
Japan
Prior art keywords
stem cells
pharmaceutical composition
exosomes
thrombin
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018568285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520365A (ja
JP6826135B2 (ja
Filing date
Publication date
Priority claimed from KR1020170080366A external-priority patent/KR101860266B1/ko
Application filed filed Critical
Priority claimed from PCT/KR2017/006776 external-priority patent/WO2018004237A1/ko
Publication of JP2019520365A publication Critical patent/JP2019520365A/ja
Publication of JP2019520365A5 publication Critical patent/JP2019520365A5/ja
Application granted granted Critical
Publication of JP6826135B2 publication Critical patent/JP6826135B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018568285A 2016-07-01 2017-06-27 トロンビン処理幹細胞に由来するエクソソームを含む皮膚傷治療用組成物 Active JP6826135B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20160083703 2016-07-01
KR10-2016-0083703 2016-07-01
KR1020170080366A KR101860266B1 (ko) 2016-07-01 2017-06-26 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 피부상처 치료용 조성물
KR10-2017-0080366 2017-06-26
PCT/KR2017/006776 WO2018004237A1 (ko) 2016-07-01 2017-06-27 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 피부상처 치료용 조성물

Publications (3)

Publication Number Publication Date
JP2019520365A JP2019520365A (ja) 2019-07-18
JP2019520365A5 true JP2019520365A5 (enExample) 2020-04-09
JP6826135B2 JP6826135B2 (ja) 2021-02-03

Family

ID=60998515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018568285A Active JP6826135B2 (ja) 2016-07-01 2017-06-27 トロンビン処理幹細胞に由来するエクソソームを含む皮膚傷治療用組成物

Country Status (5)

Country Link
US (1) US12239695B2 (enExample)
EP (1) EP3479831B1 (enExample)
JP (1) JP6826135B2 (enExample)
KR (1) KR101860266B1 (enExample)
CN (1) CN109641013B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101973284B1 (ko) 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 hie 치료용 조성물
KR102278102B1 (ko) 2018-07-27 2021-07-15 주식회사 엑소스템텍 엑소좀을 유효성분으로 포함하는 급성 간질환의 예방 또는 치료용 조성물
WO2020022541A1 (ko) 2018-07-27 2020-01-30 주식회사 엑소스템텍 엑소좀을 유효성분으로 포함하는 급성 간부전의 예방 또는 치료용 조성물
KR102323056B1 (ko) * 2019-05-02 2021-11-09 에스씨엠생명과학 주식회사 hPL 함유 배지에서 배양된 중간엽 줄기세포의 배양액을 포함하는 화장료 조성물
KR102159394B1 (ko) * 2019-10-04 2020-09-24 (주)에스디생명공학 바다제비집에서 유래된 엑소좀을 유효성분으로 포함하는 피부 상태 개선용 조성물
US12491212B2 (en) 2019-11-12 2025-12-09 Brexogen Inc. Composition for preventing or treating renal diseases, comprising exosomes derived from precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells
JP2021116228A (ja) * 2020-01-22 2021-08-10 医薬資源研究所株式会社 抗酸化ストレス剤、化粧品、および医薬品
US12077780B2 (en) 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof
KR20210127510A (ko) * 2020-04-14 2021-10-22 사회복지법인 삼성생명공익재단 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 당뇨병성 피부질환 예방 또는 치료용 조성물
CN111888379A (zh) * 2020-08-17 2020-11-06 济宁医学院附属医院 干细胞来源的微囊泡在制备修复瘢痕的制剂中的应用
EP4252761A4 (en) * 2020-11-26 2024-06-05 Samsung Life Public Welfare Foundation COMPOSITION FOR THE TREATMENT OF INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-PROCESSED STEM CELLS
CN114904043B (zh) * 2022-04-28 2023-07-21 深圳市儿童医院 复合水凝胶及其制备方法和应用
JP2025539861A (ja) * 2022-11-25 2025-12-09 エルピス・セル・セラピューティクス vMSCのセクレトームおよびその用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5911874B2 (ja) * 2010-10-18 2016-04-27 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ 発毛を促進又は増強するためのエキソソームの使用
US20150125950A1 (en) 2012-05-18 2015-05-07 Agency For Science, Technology And Research (A*Sta (A*Star) Umbilical cord mesenchymal stem cell exosomes
KR20140066456A (ko) 2012-11-23 2014-06-02 호서대학교 산학협력단 피부각질세포 유래 엑소좀, 엑소좀을 포함하는 분획물의 피부재생용 화장품 조성물 및 이의 용도
GB201317889D0 (en) * 2013-10-09 2013-11-20 Reneuron Ltd Product and use
JP6343671B2 (ja) * 2013-12-12 2018-06-13 サムスン ライフ パブリック ウェルフェア ファウンデーション トロンビンを利用した幹細胞由来のエキソソームの生成促進方法
US9919011B2 (en) * 2014-03-18 2018-03-20 Samsung Life Public Welfare Foundation Method for treating an inflammatory brain disease comprising administering a stem cell-derived exosome
CN105477016A (zh) * 2015-11-13 2016-04-13 中国人民解放军第二军医大学 人间充质干细胞来源的外泌体在抗组织纤维化及瘢痕形成中的应用

Similar Documents

Publication Publication Date Title
JP2019520365A5 (enExample)
Xie et al. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
RU2759508C1 (ru) Композиция, включающая экзосому, полученную из стволовых клеток, для индукции адипогенной дифференцировки, регенерации жировой ткани, отбеливания кожи или коррекции морщин
da Silva et al. Stem cell-containing hyaluronic acid-based spongy hydrogels for integrated diabetic wound healing
US9682104B2 (en) Lyophilized platelet lysates
US12239695B2 (en) Composition comprising thrombin-treated stem cell-derived exosome for treating skin wound
Zhan et al. Macrophage-derived microvesicles promote proliferation and migration of Schwann cell on peripheral nerve repair
RU2015137965A (ru) Сывороточная фракция обогащенного тромбоцитами фибрина
JP2023105066A (ja) 組織治癒剤
TW201922276A (zh) 間葉系幹細胞引誘劑
Nie et al. Non-stem cell-derived exosomes: a novel therapeutics for neurotrauma
Wang et al. Diverse-Origin Exosomes Therapeutic Strategies for Diabetic Wound Healing
Wang et al. Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers
Mester et al. Stem cell therapy in wound healing
Mörschbächer et al. Treatment of dilated cardiomyopathy in rabbits with mesenchymal stem cell transplantation and platelet-rich plasma
JP2016202098A (ja) マンネンタケ抽出物を用いた幹細胞の未分化状態維持剤及び増殖促進剤
JP2015061536A5 (enExample)
EP2431046B1 (en) Use of olive leaf extracts in a pharmaceutical composition for inducing angiogenesis and vasculogenesis
JP5251873B2 (ja) 脂肪組織細胞画分の照射後組織再生への使用
Aidarova et al. Applications of cord blood cells in neurology
Trivisonno et al. Adipose tissue: from energy reservoir to a source of cells for epithelial tissue engineering
KR102633660B1 (ko) 효능이 증진된 줄기세포 유래 세포외소포를 포함하는 상처 치료용 조성물
Chandra et al. Role of the Immune System in Wound Healing and Strategies to Modulate Immune Responses to Promote Wound Healing
KR101616386B1 (ko) 퍼페니돈을 유효성분으로 함유하는 비부비동염의 예방 및 치료용 조성물
Liang et al. Cell-Free and Cell-Based Therapy in Regenerative Medicine